Moberg Pharma AB (publ)
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2019-07-01 | Moberg Pharma AB (publ) | Torbjörn Wärnheim | SVP R&D | Disposal | 7 500 | 66,672 | SEK | 500 041,5 | 2019-06-27 |
| 2019-06-29 | Moberg Pharma AB (publ) | Annika Christine Magnusson | Senior Director Regulatory Affairs | Disposal | 15 000 | 66,672 | SEK | 1 000 083 | 2019-06-27 |
| 2019-06-29 | Moberg Pharma AB (publ) | Annika Christine Magnusson | Senior Director Regulatory Affairs | Subscription | 6 227 | 59,5 | SEK | 370 506,5 | 2019-06-27 |
| 2019-06-29 | Moberg Pharma AB (publ) | Annika Christine Magnusson | Senior Director Regulatory Affairs | Disposal | 6 227 | 66,672 | SEK | 415 167,789 | 2019-06-27 |
| 2019-06-29 | Moberg Pharma AB (publ) | Annika Christine Magnusson | Senior Director Regulatory Affairs | Subscription | 15 000 | 42,97 | SEK | 644 550 | 2019-06-27 |
| 2019-06-27 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | VD | Disposal | 1 994 | 65,3 | SEK | 130 208,2 | 2019-06-24 |
| 2019-06-27 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | VD | Acquisition | 1 994 | 65,2 | SEK | 130 008,8 | 2019-06-25 |
| 2019-05-22 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | VD | Allotment | 1 994 | 66,8 | SEK | 133 199,2 | 2019-05-19 |
| 2019-05-22 | Moberg Pharma AB (publ) | Torbjörn Wärnheim | SVP R&D | Allotment | 2 135 | 66,8 | SEK | 142 618 | 2019-05-19 |
| 2019-05-20 | Moberg Pharma AB (publ) | Annika Christine Magnusson | Senior Director, Regulatory Affairs | Allotment | 1 499 | 67,2 | SEK | 100 732,8 | 2019-05-16 |
| 2019-05-20 | Moberg Pharma AB (publ) | Sarah Hellerfelt | Ekonomi/finanschef | Allotment | 688 | 67,2 | SEK | 46 233,6 | 2019-05-16 |
| 2018-09-14 | Moberg Pharma AB (publ) | Shaw Sorooshian | Chief Medical Officer | Acquisition | 5 399 | 53,45 | SEK | 288 576,55 | 2018-09-06 |
| 2018-06-29 | Moberg Pharma AB (publ) | Torbjörn Wärnheim | VP Pharm Dev | Acquisition | 3 000 | 32,45 | SEK | 97 350 | 2018-06-28 |
| 2018-03-16 | Moberg Pharma AB (publ) | Jeffrey Vernimb | Vice President, Global Consumer Health | Acquisition | 3 200 | 3,1 | USD | 9 920 | 2018-03-11 |
| 2018-03-09 | Moberg Pharma AB (publ) | TORBJÖRN WÄRNHEIM | Director Pharmaceutical Innovation Development | Acquisition | 1 500 | 23,9 | SEK | 35 850 | 2018-03-08 |
| 2017-12-21 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | Ekonomi/finanschef | Disposal | 12 000 | 28,2 | SEK | 338 400 | 2017-12-20 |
| 2017-12-21 | Moberg Pharma AB (publ) | Anna Helena Constance Ljung | Ekonomi/finanschef | Acquisition | 12 000 | 28,2 | SEK | 338 400 | 2017-12-20 |
| 2017-12-11 | Moberg Pharma AB (publ) | Peter Wolpert | VD | Disposal | 435 399 | 26,5 | SEK | 11 538 073,5 | 2017-12-05 |
| 2017-12-11 | Moberg Pharma AB (publ) | Peter Wolpert | VD | Acquisition | 435 399 | 26,5 | SEK | 11 538 073,5 | 2017-12-05 |
| 2017-06-08 | Moberg Pharma AB (publ) | Jeffrey Vernimb | General Manager, North America | Acquisition | 2 782 | 51,01 | SEK | 141 909,82 | 2017-06-06 |